Phenotypic Detection of AMR by Rapid Lateral Flow

The GADx test is a simple, easy to use lateral flow test that will detect beta-lactam antimicrobial resistance within 30 minutes, avoiding any lengthy sample processing and culture steps, and allowing healthcare providers to make an informed choice when prescribing antibiotics.

N.A.

Global Access Diagnostics (GADx) is a leading end-to-end developer of rapid immuno- diagnostics for human, veterinary and agricultural applications.
As a trusted contract research organization specializing in assay design and development, antibody engineering, validation and clinical studies, we are proud of our track record in succeeding with the most demanding of challenges. Our in-depth knowledge and technology platforms enable us to take complex customer requirements to leading-edge tailored solutions. GADx works with a global network of leaders across various capabilities to ensure innovative and quality solutions for our clients.
At GADx, our vision is to reinvest profits to develop RDTs that cater to the most pressing health needs across the globe with initiatives supporting industry, academia and not-for-profit organisations, and creating partnerships in LMICs to establish local manufacturing facilities to deliver high-quality, affordable diagnostics to underserved populations

Global Access Diagnostics (GADx) is a contract research organization specializing in assay design and development, antibody engineering, validation and clinical studies